Profile
Ranjan Batra currently works at Dyne Therapeutics, Inc., as Chief Scientific Officer from 2025 and Lexeo Therapeutics, Inc., as Vice President-Research & Translation.
Dr. Batra also formerly worked at Locanabio, Inc., as SVP-Research & Development.
Dr. Batra received his doctorate degree from the University of Florida.
Ranjan Batra active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-04-27 |
Former positions of Ranjan Batra
| Companies | Position | End |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 2025-04-01 |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Chief Tech/Sci/R&D Officer | - |
Training of Ranjan Batra
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Ranjan Batra
















